News search
 About the CNIC 30 Apr 2025 Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University |
 Research 4 Aug 2024 Laboratory of Pharmacology and Physiology of the University of Montreal (Canadá) |
 Research 6 Jul 2024 Mayo Clinic College of Medicine and Science in Jacksonville
|
 |
 Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
 |
 About the CNIC 24 Jun 2022 Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher |
 About the CNIC 18 May 2022 The project will examine long-term changes in plasma biomarkers of neuronal injury, neuroinflammation, and Alzheimer's disease in participants in the PESA-CNIC-SANTANDER study who have undergone imaging studies to map brain metabolism. The goal of the project is to determine how cardiovascular risk factors during midlife impact brain function |
 About the CNIC 6 Jul 2021 This project represents a major development in the need to implement early cardiovascular intervention strategies that are capable of reducing the incidence of AD at the advanced ages in Alzheimer's disease |
 Research 15 Feb 2021 Among the modifiable cardiovascular risk factors showing a close association with reduced brain metabolism, the research team found that the most important is hypertension |
- 1 of 2
- next ›
